UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.965

Sortiert nach

Effective of metastasis-directed therapy for de novo metastatic nasopharyngeal carcinoma: A propensity score matched analysis

Head & neck, 2023-10, Vol.45 (10), p.2571-2579

2023

Volltextzugriff (PDF)

Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose

BMC cancer, 2023-05, Vol.23 (1), p.410-410, Article 410

2023

Volltextzugriff (PDF)

Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial

Nature communications, 2024-01, Vol.15 (1), p.949-949, Article 949

2024

Volltextzugriff (PDF)

Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial

Nature communications, 2024-02, Vol.15 (1), p.1029-1029, Article 1029

2024

Volltextzugriff (PDF)

A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients

Ai zheng, 2016-06, Vol.35 (11), p.617-624, Article 59

2016

Volltextzugriff (PDF)

Elevated Levels of TNF-α and Decreased Levels of CD68-Positive Macrophages in Primary Tumor Tissues Are Unfavorable for the Survival of Patients With Nasopharyngeal Carcinoma

Technology in cancer research & treatment, 2019, Vol.18, p.1533033819874807-1533033819874807

2019

Volltextzugriff (PDF)

Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor

Frontiers in immunology, 2023-01, Vol.14, p.1069010-1069010

2023

Volltextzugriff (PDF)

Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival

Biology of sex differences, 2021-01, Vol.12 (1), p.18-18, Article 18

2021

Volltextzugriff (PDF)

Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma

JAMA network open, 2021-09, Vol.4 (9), p.e2124721-e2124721

2021

Volltextzugriff (PDF)

Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area

European journal of cancer (1990), 2017-03, Vol.73, p.48-60

2017

Volltextzugriff (PDF)

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling

Journal of experimental & clinical cancer research, 2018-04, Vol.37 (1), p.85-85, Article 85

2018

Volltextzugriff (PDF)

Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial

BMC cancer, 2017-02, Vol.17 (1), p.134-134, Article 134

2017

Volltextzugriff (PDF)

The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapy

PloS one, 2013-10, Vol.8 (10), p.e76958-e76958

2013

Volltextzugriff (PDF)

A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma

Journal of inflammation research, 2021-01, Vol.14, p.817-828

2021

Volltextzugriff (PDF)

Occipital lymph node metastasis from nasopharyngeal carcinoma:a special case report and literature review

Ai zheng, 2016-01, Vol.35 (4), p.196-203, Article 1

2016

Volltextzugriff (PDF)

Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score‐matched analysis

Cancer communications (London, England), 2018-05, Vol.38 (1), p.1-10

2018

Volltextzugriff (PDF)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial

European journal of cancer (1990), 2017-04, Vol.75, p.14-23

2017

Volltextzugriff (PDF)

Elevated peripheral blood lymphocyte‐to‐monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma

Ai zheng, 2015-06, Vol.34 (3), p.1-10, Article 23

2015

Volltextzugriff (PDF)

Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy

Journal of inflammation research, 2021-01, Vol.14, p.2225-2237

2021

Volltextzugriff (PDF)

Prognostic value of early radiological response to first‐line platinum‐containing chemotherapy in patients with metastatic nasopharyngeal carcinoma

Cancer medicine (Malden, MA), 2020-02, Vol.9 (3), p.920-930

2020

Volltextzugriff (PDF)

The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area

Therapeutic advances in medical oncology, 2018-01, Vol.10, p.1758835918782331-1758835918782331

2018

Volltextzugriff (PDF)

Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma

Cancer cell international, 2016-07, Vol.16 (1), p.54-54, Article 54

2016

Volltextzugriff (PDF)

A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinoma

iScience, 2023-12, Vol.26 (12), p.108347-108347, Article 108347

2023

Volltextzugriff (PDF)

1 – 25 von 1.965

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.634)
Mit Volltextzugriff
(1.784)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.718)
Chinesisch
(240)
Japanisch
(108)
Koreanisch
(5)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.308)
Life Sciences & Biomedicine
(804)
Humans
(506)
Physical Sciences
(348)
Female
(278)
Male
(274)
Technology
(273)
Animals
(249)
Chemistry
(236)
Adult
(168)
Materials Science
(156)
Middle Aged
(155)
Oncology
(148)
Science & Technology - Other Topics
(139)
Mice
(131)
Materials Science, Multidisciplinary
(123)
Engineering
(105)
Aged
(102)
Physics
(97)
Chemistry, Multidisciplinary
(94)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Scientific Reports
(25)
中华医学杂志
(23)
Chinese Physics Letters
(21)
Nature Communications
(18)
Plos One
(18)
食品安全质量检测学报
(16)
Angewandte Chemie
(15)
Angewandte Chemie International Edition
(15)
Oncotarget
(15)
World Journal Of Gastroenterology : Wjg
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(48)
... seit 30 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Effective of metastasis-directed therapy for de novo metastatic nasopharyngeal carcinoma: A propensity score matched analysis

Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose

Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial

Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial

A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients

Elevated Levels of TNF-α and Decreased Levels of CD68-Positive Macrophages in Primary Tumor Tissues Are Unfavorable for the Survival of Patients With Nasopharyngeal Carcinoma

Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor

Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival

Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma

Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling

Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial

The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapy

A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma

Occipital lymph node metastasis from nasopharyngeal carcinoma:a special case report and literature review

Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score‐matched analysis

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial

Elevated peripheral blood lymphocyte‐to‐monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma

Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy

Prognostic value of early radiological response to first‐line platinum‐containing chemotherapy in patients with metastatic nasopharyngeal carcinoma

The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area

Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma

A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinoma

Suchergebnisse filtern